Jermaine Eluemunor #72 of the New York Giants

...

Matthew Davis

By Matthew Davis

0

Share

Newsweek is a Trust Project member

See more of our trusted coverage when you search.Prefer Newsweek on Googleto see more of our trusted coverage when you search.


Amid the World Cup transforming MetLife Stadium’s turf into a grass field, New York Giants offensive lineman Jermaine Eluemunor can’t stand it.

MetLife is one of the seven NFL stadiums that switched to grass to host World Cup games this summer. The NFLPA has been vocal for years about grass instead of turf, while the league has refused to go away from primarily turf fields.

“It was a kind of (a) sucky feeling,” Eluemunor said via NBC News.

Read More on NFL

MetLife hosted four Group Stage matches thus far, and the final one is Saturday between England and Panama. The Giants’ home will then host three knockout round matches, and that includes the championship match. That game could draw 1.5 billion or more viewers if it matches or surpasses 2022.

Jermaine Eluemunor #72 of the New York Giants

...

Whether or not Eluemunor follows the World Cup at MetLife or anywhere else, he doesn’t need to imagine the difference between grass and turf. He plays at least nine games every season on turf between MetLife and a road game against the Dallas Cowboys. The Giants at least play the Philadelphia Eagles and Washington Commanders, both of which have grass fields.

“I’m going into year 10, and I can say wholeheartedly that grass feels way better than turf,” Eluemunor said. “With MetLife getting grass, obviously it’s cool for FIFA and the World Cup.”

“It’s one of the biggest stages in the world, but, at the same time, the NFL as a whole is one of the most profitable businesses in the world, and so you would think that we as players would have a say in the fields that we get to play on,” Eluemunor added.

Eluemunor is far from the only player speaking out, and there could be more in the coming weeks as the all-grass World Cup holds center stage in North America.

View 0 Comments

Request Reprint & Licensing

Submit Correction

View Editorial & AI Guidelines